Pathogenesis	O
of	O
thrombosis	O
in	O
essential	O
thrombocythemia	O
and	O
polycythemia	O
vera	O
:	O
the	O
role	O
of	O
neutrophils	B-Cell
.	O

Thrombotic	O
complications	O
are	O
frequently	O
observed	O
in	O
patients	O
with	O
polycythemia	O
vera	O
(	O
PV	O
)	O
and	O
essential	O
thrombocythemia	O
(	O
ET	O
)	O
.	O

Abnormalities	O
of	O
red	B-Cell
blood	I-Cell
cells	I-Cell
and	O
platelets	B-Cell
arising	O
from	O
the	O
clonal	O
rearrangement	O
of	O
hematopoietic	B-Cell
cells	I-Cell
have	O
been	O
considered	O
,	O
although	O
causal	O
relationships	O
between	O
any	O
of	O
these	O
specific	O
abnormalities	O
and	O
thrombosis	O
have	O
not	O
been	O
clearly	O
established	O
.	O

The	O
involvement	O
of	O
neutrophils	B-Cell
and	O
macrophages	B-Cell
,	O
which	O
participate	O
in	O
thrombosis	O
and	O
hemostasis	O
,	O
has	O
been	O
insufficiently	O
explored	O
in	O
PV	O
and	O
ET	O
.	O

Persistent	O
activation	O
of	O
circulating	O
neutrophils	B-Cell
was	O
recently	O
demonstrated	O
in	O
ET	O
and	O
PV	O
patients	O
,	O
in	O
parallel	O
with	O
an	O
increase	O
in	O
plasma	B-Organism_substance
concentrations	O
of	O
endothelial	B-Tissue
damage	O
-	O
derived	O
and	O
prothrombotic	O
substances	O
.	O

Other	O
studies	O
have	O
explored	O
whether	O
the	O
augmentation	O
of	O
adhesion	O
of	O
neutrophils	B-Cell
may	O
affect	O
neutrophil	B-Cell
/	O
platelet	B-Cell
interaction	O
since	O
a	O
significant	O
increase	O
in	O
circulating	O
neutrophil	B-Cell
/	O
platelet	B-Cell
aggregates	O
is	O
found	O
in	O
ET	O
and	O
PV	O
.	O

This	O
review	O
summarizes	O
the	O
current	O
knowledge	O
of	O
the	O
pathogenesis	O
of	O
thrombosis	O
in	O
PV	O
and	O
ET	O
,	O
with	O
emphasis	O
on	O
the	O
role	O
of	O
neutrophils	B-Cell
in	O
hemostasis	O
and	O
their	O
possible	O
involvement	O
in	O
the	O
mechanisms	O
of	O
the	O
acquired	O
thrombophilia	O
of	O
these	O
patients	O
.	O

Available	O
data	O
suggest	O
that	O
these	O
hemostatic	O
markers	O
deserve	O
to	O
be	O
included	O
in	O
prospective	O
clinical	O
studies	O
aimed	O
at	O
identifying	O
their	O
predictive	O
role	O
in	O
the	O
vascular	B-Multi-tissue_structure
complications	O
of	O
patients	O
with	O
ET	O
and	O
PV	O
.	O

